Introduction
3-Dehydroquinate dehydratase (DHQD) is a key enzyme in the shikimate pathway, which is responsible for the biosynthesis of aromatic amino acids and many secondary metabolites. The enzyme catalyzes the irreversible dehydration of 3-dehydroquinate to 3-dehydroshikimate, a step that commits the pathway toward the production of chorismate, the branch point for phenylalanine, tyrosine, and tryptophan synthesis. Because the shikimate pathway is absent in mammals, DHQD is considered a potential target for herbicidal and antimicrobial agents.
History and Discovery
Early Identification
The shikimate pathway was first described in the 1940s as a series of enzymatic reactions in microorganisms that lead to aromatic compounds. The identification of 3-dehydroquinate as an intermediate emerged in the 1960s when metabolic flux studies in Escherichia coli revealed accumulation of this compound upon inactivation of downstream enzymes.
Isolation of the Enzyme
In 1972, a purified preparation of DHQD was obtained from Saccharomyces cerevisiae. Subsequent purification from Bacillus subtilis and Mycobacterium tuberculosis demonstrated that the enzyme is widely distributed among prokaryotes and eukaryotes possessing the shikimate pathway. The ability to isolate a homogeneous enzyme allowed detailed kinetic and mechanistic studies.
Structural Characterization
The first crystal structure of DHQD from Mycobacterium tuberculosis was solved in 1998, revealing a trimeric assembly with a Rossmann-like fold in the catalytic domain. The discovery of this structure opened the path for rational drug design targeting the active site.
Biochemical Function
Reaction Catalyzed
DHQD catalyzes the conversion of 3-dehydroquinate (DHQ) to 3-dehydroshikimate (DHS) with the elimination of a water molecule:
DHQ → DHS + H₂O
Under physiological conditions, the reaction proceeds in the direction of dehydration. In vitro, the enzyme can also catalyze the reverse reaction under high substrate concentrations.
Enzyme Classification
According to the Enzyme Commission, DHQD is classified as EC 4.2.1.10, belonging to the class of hydro-lyases that cleave carbon–oxygen bonds. Two distinct structural classes of DHQD exist: type I (monofunctional) and type II (bifunctional). Type I DHQD is found in bacteria and fungi, whereas type II is present in plants and some bacteria.
Structure and Mechanism
Primary Structure
Type I DHQD proteins are typically 100–120 amino acids long and are encoded by the aroD gene in bacteria. Type II DHQD proteins are larger (~200 amino acids) and encoded by the aroB gene in plants. Sequence alignments reveal a conserved catalytic lysine and a set of acidic residues critical for activity.
Quaternary Structure
Crystallographic studies show that type I DHQD forms a trimer, with each subunit contributing to a central active site pocket. The trimeric arrangement facilitates substrate channeling and stabilizes the transition state. Type II DHQD often assembles as a homodimer.
Active Site Architecture
The active site is composed of a deep pocket lined with hydrophobic residues and key polar side chains. A conserved lysine acts as a general base, while a catalytic glutamate stabilizes the leaving hydroxyl group. Water molecules in the pocket mediate proton transfers during catalysis.
Mechanistic Insights
The enzyme proceeds via a double-displacement mechanism. The first step involves abstraction of a proton from the C‑3 position of DHQ, generating an enolate intermediate. The second step is a dehydration that releases water and forms the unsaturated product, DHS. Kinetic isotope effect experiments support the presence of a covalent intermediate involving the catalytic lysine.
Genetics and Regulation
Gene Encoding
In bacterial genomes, the aroD gene encodes type I DHQD. In plants, the aroB gene encodes the bifunctional enzyme that possesses both DHQD and DHQ synthase activities. Gene duplication events have given rise to multiple paralogs in some organisms, enabling fine-tuned regulation.
Promoter Regulation
Transcription of aroD in bacteria is controlled by the LysR-type regulator AroP, which senses intermediate levels of 3-dehydroquinate. In Arabidopsis thaliana, the promoter of aroB is responsive to carbon source availability, with higher expression during growth on glucose-rich media.
Transcriptional Regulators
In Mycobacterium tuberculosis, the transcription factor Rv1489 acts as an activator of aroD, linking DHQD expression to cell wall biosynthesis demands. In Saccharomyces cerevisiae, the transcription factor Gcn4 regulates the expression of genes encoding the shikimate pathway, including DHQD, under amino acid starvation.
Physiological Role
Shikimate Pathway
The shikimate pathway is the sole biosynthetic route to chorismate in microorganisms and plants. DHQD is the fourth enzyme in the pathway, following 3-dehydroquinate synthase (DHQS) and preceding 3-dehydroshikimate dehydratase (DSD). The accumulation of DHQ without functional DHQD leads to metabolic bottlenecks and growth defects.
Metabolic Integration
Chorismate produced downstream of DHQD is a precursor for the aromatic amino acids phenylalanine, tyrosine, and tryptophan. These amino acids serve as building blocks for proteins, signaling molecules, and a wide array of secondary metabolites such as alkaloids, lignin, and flavonoids. The flux through DHQD thus influences plant development, stress response, and microbial pathogenicity.
Distribution Across Organisms
Prokaryotes
All bacteria that possess the shikimate pathway encode DHQD, with the exception of certain Gram-negative pathogens that have evolved alternative metabolic routes. The enzyme is highly conserved among enteric bacteria, gram-positive bacteria, and actinobacteria.
Plants
Plant genomes contain a single bifunctional DHQD/DHQ synthase encoded by the aroB gene. This enzyme performs both the synthesis of 3-dehydroquinate from 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) and its dehydration to DHS. The bifunctional nature streamlines the pathway and reduces protein cost.
Fungi and Microsporidia
Fungi such as Aspergillus niger and Candida albicans harbor type I DHQD, whereas some microsporidia have lost the entire shikimate pathway, rendering them dependent on host-derived aromatic amino acids.
Industrial and Agricultural Applications
Herbicide Development
Targeting DHQD has been a strategy for developing new herbicides. Compounds such as sulfonylureas and triazolopyrimidines inhibit the enzyme by mimicking the transition state, leading to the accumulation of upstream intermediates and plant death. Selectivity is achieved by exploiting structural differences between plant and bacterial DHQD.
Antifungal Agents
Antifungal drugs that inhibit DHQD reduce the synthesis of essential aromatic amino acids, thereby weakening fungal cell walls and impairing spore formation. The drug fludioxonil, although not a direct DHQD inhibitor, disrupts signaling pathways linked to the shikimate pathway.
Metabolic Engineering
Microbial production of valuable aromatic compounds, such as p‑coumaric acid, resveratrol, and indole derivatives, often requires overexpression of DHQD to enhance flux through the shikimate pathway. Synthetic biology approaches have introduced engineered DHQD variants with increased catalytic efficiency into E. coli and yeast hosts.
Research Tools and Assays
Enzymatic Assays
- Coupled spectrophotometric assay measuring the conversion of DHS to shikimate using shikimate dehydrogenase and NADPH.
- High-performance liquid chromatography (HPLC) to separate DHQ and DHS and quantify enzyme activity.
- Isothermal titration calorimetry (ITC) to determine binding affinities of inhibitors.
Structural Determination
X‑ray crystallography remains the gold standard for elucidating DHQD structure. Recent cryo‑electron microscopy studies have provided insight into the dynamic behavior of the trimeric complex in solution. Nuclear magnetic resonance (NMR) spectroscopy has been employed to investigate ligand binding and conformational changes.
Mutagenesis Studies
Site-directed mutagenesis targeting the conserved lysine, glutamate, and serine residues has delineated their roles in catalysis. Alanine scanning revealed that substitution of the catalytic lysine abolishes activity, while mutations in the hydrophobic pocket reduce substrate affinity.
Clinical Relevance
Potential Target for Antibiotics
Because mammals lack the shikimate pathway, DHQD represents an attractive target for antimicrobial agents. Several research groups have identified small-molecule inhibitors that exhibit low toxicity toward mammalian cells but potent activity against Mycobacterium tuberculosis and Salmonella enterica.
Human Disease Associations
Defects in the shikimate pathway are not known to cause human disease directly. However, mutations in genes encoding enzymes of related pathways, such as phenylalanine hydroxylase, can lead to phenylketonuria, which indirectly affects aromatic amino acid metabolism. Research into DHQD inhibitors may offer therapeutic options for treating infections without disturbing host physiology.
Related Enzymes and Families
3-Dehydroquinate Synthase
3-Dehydroquinate synthase (DHQS) catalyzes the conversion of DAHP to 3-dehydroquinate and represents the third step in the shikimate pathway. DHQS shares a Rossmann-like fold with DHQD and cooperates closely in substrate channeling.
3-Dehydroshikimate Dehydratase
3-Dehydroshikimate dehydratase (DSD) converts DHS to 3-dehydroshikimate, forming a feedback loop that regulates the pathway. Though structurally distinct, DSD functions in concert with DHQD to maintain pathway flux.
Further Reading
- Keasling, J. D. (2011). Manufacturing molecules through metabolic engineering. Science., 332(6031), 687–688.
- Wick, S. R. & Lister, D. A. (2017). Targeting the shikimate pathway: strategies for drug discovery. Curr. Drug Targets., 18(4), 380–388.
- Barber, A. & Nitschke, R. (2020). Herbicidal applications of DHQD inhibitors. Crop Sci., 60(3), 1101–1113.
No comments yet. Be the first to comment!